SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Solomon D, Davey D, Kurman R, et al; Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002; 287: 2114-2119.
  • 2
    Wright TCJr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D; 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007; 197: 346-355.
  • 3
    Walsh BG, Michaels S, Steele C, Khurana KK. Clinical significance of the Pap smear diagnosis of LSIL cannot exclude HSIL: comparison with a patient population with Pap smear findings of LSIL [abstract]. Acta Cytol. 2000; 44: 857.
  • 4
    McGrath CM, Kurtis JD, Yu GH. Evaluation of mild-to-moderate dysplasia on cervical-endocervical (Pap) smear: a subgroup of patients who bridge LSIL and HSIL. Diagn Cytopathol. 2000; 23: 245-248.
  • 5
    Kir G, Cetiner H, Gurbuz A, Karateke A. Reporting of “LSIL with ASC-H” on cervicovaginal smears: is it a valid category to predict cases with HSIL follow-up? Eur J Gynaecol Oncol. 2004; 25: 462-464.
  • 6
    Shidham VB, Kumar N, Narayan R, Brotzman GL. Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath specimens with review of literature. Cytojournal. 2007; 4: 7.
  • 7
    Elsheikh TM, Kirkpatrick JL, Wu HH. The significance of “low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion” as a distinct squamous abnormality category in Papanicolaou tests. Cancer (Cancer Cytopathol). 2006; 108: 277-281.
  • 8
    Nasser SM, Cibas ES, Crum CP, Faguin WC. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion. Cancer (Cancer Cytopathol). 2003; 99: 272-276.
  • 9
    Booth C, Massarani-Wafai R, Salhadar A, Weirick J, Wojcik EM. Is LSIL cannot exclude HSIL (LGHSIL) a valid Pap test interpretation [abstract]. Mod Pathol. 2005; 18: 61A.
  • 10
    Power P, Gregoire J, Duggan MA, Nation J. Low-grade pap smears containing occasional high-grade cells as a predictor of high-grade dysplasia. J Obstet Gynaecol Can. 2006; 28: 884-887.
  • 11
    Jain R, Pedigo MA, Powers CN, Frable WJ. Significance of reporting “LSIL-H” on cervical specimens [abstract]. Cancer (Cancer Cytopathol). 2005; 105(suppl 5): 355. Abstract 55.
  • 12
    Difurio MJ, Mailhiot T, Sundborg MJ, Nauschuetz KK. Comparison of the clinical significance of the Papanicolaou test interpretations LSIL cannot rule out HSIL and ASC-H. Diagn Cytopathol. 2010; 38: 313-317.
  • 13
    Baker JJ, Fontana JL. “LSIL-H” cervicovaginal cytology specimens: biopsy follow-up and clinical significance [abstract]. Acta Cytol. 2004; 48: 668.
  • 14
    Saad RS, Mahdavy M, Takei H, Ruiz B. Clinical significance of cytologic diagnosis of low-grade squamous intraepithelial lesion with few cells suggestive of high grade: a cytohistologic correlation study [abstract]. Acta Cytol. 2004; 48: 659.
  • 15
    Underwood D, Prok A, Booth C, Brainard J, Chen L. Clinical outcomes of patients with a cytologic interpretation of “LSIL cannot exclude HSIL (LSIL-H)” in Pap test: a retrospective follow-up study [abstract]. Cancer (Cancer Cytopathol). 2006; 108(suppl 5): 378.
  • 16
    Howard MT, Cohen DW, Underwood DL, Deeds DA, Booth CN. Utilization of ASC-H, LSIL, cannot exclude HSIL (LSIL-H) and HSIL terminology after implementation of the ThinPrep imaging system [abstract]. Mod Pathol. 2007; 20: 71A.
  • 17
    Owens CL, Moats DR, Burroughs FH, Gustafson KS. “Low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion” is a distinct cytologic category: histologic outcomes and HPV prevalence. Am J Clin Pathol. 2007; 128: 398-403.
  • 18
    Hong SR, Kim BM, Park JS, Choi KJ, Kim HS. Evaluation of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion on cervical smear [abstract 61]. Cancer (Cancer Cytopathol). 2007; 111(suppl 5): 387.
  • 19
    Al-Nourhji O, Beckmann MJ, Markwell SJ, Massad LS. Pathology correlates of a Papanicolaou diagnosis of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion. Cancer. 2008; 114: 469-473.
  • 20
    Hunter C, Duggan MA, Duan Q, Power P, Gregoire J, Nation J. Cytology and outcome of LSIL: cannot exclude HSIL compared to ASC-H. Cytopathology. 2009; 20: 17-26.
  • 21
    Alsharif M, Kjeldahl K, Curran C, Miller S, Gulbahce HE, Pambuccian SE. Clinical significance of the diagnosis of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion. Cancer (Cancer Cytopathol). 2009; 117: 92-100.
  • 22
    Kumar N, Parameswaran L, Cafaro A, et al. LSIL with ASC-H in cervical smears—should it be an independent category for proper management and QA statistics [abstract 61]? Cancer (Cancer Cytopathol). 2005; 105(suppl 5): 381.
  • 23
    O'Brien D, Brainard J, Chen L, Prok A, Booth C. Impact of the ThinPrep imaging system on the frequency of LSIL, cannot exclude HSIL: correlation on HPV and follow-up [abstract]. Cancer (Cancer Cytopathol). 2006; 108(suppl 5): 383. Abstract 71.
  • 24
    Ince U, Aydin O, Peker O. Clinical importance of “low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)” terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature. Gynecol Oncol. 2011; 121: 152-156.
  • 25
    Sherman ME, Abdul-Karim FW, Berec JS, Powers CN, Sidawy MK, Tabbara SO. Atypical squamous cells. In: Solomon D, Nayar R, eds. The Bethesda System for Reporting Cervical Cytology. Definitions, Criteria, and Explanatory Notes. 2nd ed. New York: Springer; 2004: 67-89.
  • 26
    Chivukula M, Shidham VB. ASC-H in Pap test–definitive categorization of cytomorphological spectrum. Cytojournal. 2006; 3: 14.
  • 27
    International Agency for Research on Cancer (IARC) Monographs: Human Papillomaviruses. Vol 100b. Lyon, France: International Agency for Research on Cancer; 2009. http://monographs.iarc.fr/ENG/Monographs/vol100B/mono100B-11.pdf. Accessed May 7, 2012.
  • 28
    Schiffman M, Castle PE. The promise of global cervical-cancer prevention. N Engl J Med. 2005; 353: 2101-2104.
  • 29
    Saab BA, Austin RM. Management of squamous intraepithelial lesions of indeterminate grade. Am J Obstet Gynecol. 2008; 199: e13-e14; author reply e14.
  • 30
    Apgar BS, Kittendorf AL, Bettcher CM, Wong J, Kaufman AJ. Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology. Am Fam Physician. 2009; 80: 147-155.